Warning: For any media inquiries, please contact presse@pasteur.fr

Our press documents

You are a journalist and you would like to receive our press releases by e-mail? Please, ask to presse@pasteur.fr

Filter press documents

Candidat vaccin MV-SARS-CoV-2 : un nouveau partenariat entre l’Institut Pasteur, la CEPI, Thémis et MSD
Press release
Institut Pasteur announces recent advances in the development of one of its candidate vaccines, MV-SARS-CoV-2, using...
VIH : une fenêtre de vulnérabilité pour le renouvellement du réservoir viral après allogreffe de cellules souches
Press release
Current HIV treatments efficiently block viral multiplication but cannot cure infection as they do not target HIV...
Press release
An international effort including researchers from University of California San Francisco (UCSF), Gladstone Institutes...
Press Info
Following the emergence of COVID-19 disease in Wuhan in December 2019, syndromic surveillance was implemented in France...
Press release
Approximately four months after the initial description of cases of atypical pneumonia in Wuhan, China, in December...
Press release
The SARS-CoV-2 global pandemic has resulted in extreme measures, with several countries imposing a lockdown on their...
Press release
The Bill & Melinda Gates Medical Research Institute (Gates MRI) and the Institut Pasteur have entered into an...
Press Info
On December 31, 2019, Chinese authorities reported a cluster of pneumonia cases in Wuhan, China, most of which included...
CEPI collaborates with the Institut Pasteur in a consortium to develop COVID-19 vaccine
Press release
Consortium to be led by the Institut Pasteur and will include Themis and the University of Pittsburgh. CEPI to provide...



Subscribe to our newsletter

Back to top